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S U M M A R Y
Objectives: Hepatitis A virus (HAV), transmitted mainly through the fecal-oral route, is one of the major
causes of acute viral hepatitis worldwide. HAV is endemic in China. This study performed genetic and
evolutionary analysis of HAV isolates circulated in the country.
Methods: Clinical samples were collected and HAV nucleotide and deduced amino acid sequences were
analyzed. 70 representative sequences of HAV VP3-VP1-2A regions sampled from 1988 to 2014 were
compared and characterized using the Bayesian Markov Chain Monte Carlo approach (BEAST software,
Version1.7.5).
Results: All isolates from China in this study belonged to genotype I, with most of the samples clustering
in subgenotype IA, while several unique amino acid variants were observed. The estimated mean
substitution rate was 5.5610-4 substitutions / site / year, the time to the most recent common ancestor
of genotype I isolates in China was calculated to be around 180 years ago. Skyline plots showed the
incidence of HAV went down gradually from the mid-1990s.
Conclusions: The evolution estimations were consistent with the laboratory and epidemiological results.
Several isolates from China showed amino acid changes close to the immunodominant sites, which
needs to be further analyzed. The study results have indicated the effectiveness of improving economic
and sanitation levels together with HAV vaccination to control HAV-related infections in China.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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HAV is known to cause acute hepatitis and has signiﬁcant
implications on public health.1 HAV has been classiﬁed in six
genotypes, including three human (I, II, and III, which were further
classiﬁed into A, B, or C subgenotypes) and three simian (IV, V, and
VI) genotypes, only one serotype for HAV was found.2–3
Our earlier laboratory studies have analyzed the genetic
diversity of HAV isolates circulated in China, and calculated the
nucleotide substitution rates using partial sequences of HAV VP3-
VP1-2A genes.4–5 In this study, we sequenced more HAV isolates
from clinical specimens, and further analyzed the evolutionary
ages and mode of evolution in natural settings of HAV isolates
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).2. Materials and methods
Total viral RNA was extracted using the QIAamp Viral RNA Mini
Kit (Qiagen, USA). Ampliﬁcation reactions were achieved following
previously published papers,4-5 around 10-100 HAV isolates
obtained from serum or stool samples of acute cases of HAV
infection in China were sequenced and analyzed each year from
2001-2014. 70 representative sequences of HAV VP3-VP1-2A
regions (1731 bp) selected between 1988 and 2014 in China were
analyzed using the MEGA 5.1 and MCMC approach available in the
BEAST software package6 (Version 1.7.5): 3 from GenBank, and
67 from our previous4,5 and this study (supplement Table.1). The
GenBank accession numbers for the sequences reported in this
paper are KF006840-KF006847, KP177964, KP177965, AF357222,
AF512536, and AF485328.
jModelTest software7 2.0.1with Akaike Information Criterion was
used and GTR (general time reversible) + I (proportion of invariant
sites) + G 4 (gamma distributed rate variation with four rate
categories) was found to be the best evolutionary model in this study.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. The Bayesian Markov Chain Monte Carlo (MCMC) tree with VP3-VP1-2A regions sequences of HAV circulated in China in this study. Horizontal branches are drawn
to a scale of estimated year of divergence, with tip times reﬂecting sampling date (year). The estimated tMRCAs (time for most recent common ancestors, with their 95% HPD
values in parentheses) for the major nodes of the lineages are shown. The tMRCA estimated for HAV genotype I in China in this study was dated back to around 180 years ago
(HPD 88.13-292.07 years). HPD: 95% highest probability density. IA, IB: subgenotypes for HAV genotype I.
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relaxed clock) with constant growth demographic population
dynamic models, as implemented in the BEAST package6, were
found more ﬁtted to the dataset. The MCMC analysis was
performed with 20 million generations and sampled every 2,000
generations with 10% burnin.
The results were computed and analyzed using Tracer 1.56. The
effective sample size values for the estimated parameters in the
MCMC analysis were greater than 200. Bayesian skyline plot under
relaxed clock (UCLD) model was constructed. Statistical uncer-
tainty in the data was reﬂected in the 95% highest probability
density values (HPD).3. Results and discussion
All HAV isolates from China in this study belonged to genotype
I showing 89.6%-100.0% of nucleotide identity, while most of the
samples clustered into subgenotype IA and a few into sub-
genotype IB. The homology of the deduced amino acid sequences
was 98.2%-100%, among the 70 HAV isolates from China and the
representative HAV sequences from GenBank within the VP3-VP1
protein. Furthermore, no amino acid changes were found at the
published neutralizing sites, while several unique amino acid
changes were observed around the immunodominant sites, e.g.
LpXj1.06 VP1-115 changed from Ser to Leu5, and KfHn1394.13
Figure 2. Bayesian skyline plot showing the demographic history of HAV genotype I
in China. The x axis is in units of years before 2014, while the y axis represents
relative genetic diversity, which is equal to the product of effective population size
and generation length in years 6. The thick solid line represents the mean estimates,
and the 95% HPD (highest probability density) is shown by blue area. The decline in
relative genetic diversity from the mid-1990s can be seen.
H. Wang et al. / International Journal of Infectious Diseases 33 (2015) 156–158158VP1-112 changed from Thr to Ile, which needs to be further
investigated.
Under the best ﬁt model, the mean substitution rate
was 5.5610-4 substitutions / site /year with an HPD of
3.56x10-4-7.70x10-4, which was comparable with the published
results: 9.76x10-4 calculated with HAV VP1 full-length sequences8
and 1.99 x10-4 calculated with HAV full genome sequences9. The
higher substitution rate of HAV VP1 region may be due to the major
immunodominant site located at this capsid protein area, which
could have subjected to more immune selection pressure and
undergone more substitutions9.
The time for the most recent common ancestor (tMRCA) of HAV
genotype I isolates circulated in China could date back to around
180 years ago (HPD 88.13-292.07 years). The divergence time for
the genotype IA isolates in this study was estimated to be about
63 years ago (HPD 43.03-88.04) (Figure 1). Kulkarni et al.9
calculated that the tMRCA of genotype I was about 416 years ago
(HPD: 232-655 years) using complete HAV genome sequences
worldwide from GenBank. Therefore, the present study results
probably indicated the common ancestor of HAV genotype I might
have emerged later in China.
Bayesian skyline plot of the demographic population history of
HAV genotype I in China implied a decline in effective population
size from the mid-1990s till now (Figure 2). This plot is consistent
with most of the epidemiology surveillance studies reported in
China10. Consequently, with the improvement in economic and
sanitation conditions, especially the introduction of HAV vaccines
in the 1990s in our country, the incidence of HAV has droppedgradually ever since. In addition, several small scale HAV outbreaks
were still reported in some provinces in China, which was probably
owing to the uneven development of economic level and uneven
coverage of HAV vaccines. However, the overall trend for HAV
incidence in China has gone down gradually, as was observed from
both the Bayesian skyline plot and epidemiological reports, and
this has also indicated the effectiveness of improving economic
and sanitation levels, together with HAV vaccination to control
HAV infections in China.
In the future, collecting and sequencing more representative
HAV sequences from different areas and years in China would add
more accurate data for the estimation of various parameters.
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